Mandatory Notification of Trade
Mattias Von Haartman, Sales & Marketing Director at Navamedic ASA has of July 6 2016 acquired 5000 shares in Navamedic ASA at an average price of NOK 9,40 per share. Following this transaction Mr Von Haartman holds a total of 10 000 shares in Navamedic ASA.
Navamedic ASA: Ends partnership with Aspen Pharma in 2017
Oslo, 5 July 2016 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced that its partnership agreement with pharmaceutical manufacturer Aspen Pharmacare Holdings ("Aspen") for distribution of products in the Nordics, will not be renewed from mid-May 2017. The partnership termination is in line with Navamedic's 13 June 2016 announcement on the strategic partnership with TopRidge Pharma Limited.